维普期刊资源整合服务平台（V6.5）

303篇 您的检索式：作者名="Spigel"

选中清除导出查看参考文献查看引证文献引用追踪共16页首页上一页第1页下一页末页 /16 跳转

	题名	作者	年代	出处	被引量
1	A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy显示文摘	Gy?rgy Bodoky Constanta Timcheva David Spigel Phillip Stella Tudor Ciuleanu G. Pover N. Tebbutt	2012	Investigational New Drugs2012，，3：	2
2	Treatment of metastatic renal cell carcinoma with a combination of bevacizu-nab and erlotinib显示文摘	Hainsworth J D Sosman J A Spigel D R	2005	J Clin Oncol2005，23，31：	1
3	Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib显示文摘	Hainsworth JD Sosman JA Spigel DR	2005	J Clin Oncol2005，23，31：	1
4	Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer显示文摘	David R. Spigel Thomas J. Ervin Rodryg A. Ramlau Davey B. Daniel Jerome H. Goldschmidt George R. Blumenschein Maciej J. Krzakowski Gilles Robinet Benoit Godbert Fabrice Barlesi Ramaswamy Govindan Taral Patel Sergey V. Orlov Michael S. Wertheim Wei Yu Jipi	2013	Journal of Clinical Oncology2013，，32：	1
5	Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotini 显示文摘	Hainsworth JD Sosman JA Spigel DR	2005	J Clin Omcol2005，23，22：	1
6	Weekly docetaxel versus docetaxel/ gemcitabine in the treatment of elderly or poor performance status patients with advanced non small cell lung cancer:a randomized phase 3 trial of the Minnie Pearl Cancer Research Network显示文摘	Hainsworth JD Spigel DR Farley C	2007	Cancer2007，110，9：	1
7	ASCEND-2: A single-arm, open-label, multicenter phase II study of ceritinib in adult patients (pts) with ALK- rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with chemotherapy and crizotinib (CRZ)显示文摘	Mok T Spigel D Felip E	2015	J Clin Oncol2015，33，：	1
8	Phase II study of main?tenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer显示文摘	Spigel DR Greco FA Rubin MS et a1	2012	Lung Cancer2012，77，2：	1
9	Randomized phase Utrial of onartuzumab in combination with erlotinib in patients withadvanced non-small-cell lung cancer显示文摘	Spigel DR Ervin TJ Ramlau RA	2013	J Clin Oncol2013，31，32：	1
10	Phase Ⅱ trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small cell lung cancer显示文摘	Shipley D Spigel DR Burris HA	2010	J Clin Oneol(Meeting Abstracts)2010，28，15：	1
11	The spatial economy of North American trade fairs显示文摘	BATHELT H SPIGEL B	2012	Canadian Geographer2012，56，1：	1
12	Phase II Trial of Bevacizumab and everolimus in patients with advanced renal cell carcinoma 显示文摘	Hainsworth JD Spigel DR Burris HA 3rd	2010	J Clin Oncol2010，，：	1
13	A randomized phase II trial of mapatumumab, a TRAIL-R1 agonist monoelonal antibody, in combination with earboplatin and paelitaxel in patients with ad- vanced NSCLC 显示文摘	Von Pawel J Harvey JH Spigel DR	2010	J Clin Oneol2010，28，：	1
14	Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase I1 trial of the Minnie Pearl Cancer Research Network 显示文摘	Spigel DR Hainsworth JD Simons L	2007	J Thorac Oncol2007，2，9：	1
15	Chemotherapy in metastatic and locally ad- vanced non-small cell lung cancer显示文摘	Spigel DR Greco FA	2003	Semin Surg Oncol2003，21，2：	1
16	First-line gefitinib inpa- tientswith advanced non-small-cell lung cancer harboring somatic EGFR mutations 显示文摘	Sequist LV Martins RG Spigel D	2008	J ClinOncol2008，26，15：	1
17	Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma显示文摘	Hainsworth J D Spigel D R Burris H R	2010	J Clin Oncol2010，28，13：	1
18	Chemotherapy in metastatic and locally advanced non - small cell lung cancer 显示文摘	Spigel DR Greco FA	2003	Simin Surg Oncol2003，21，2：	1
19	Phase II study of bev- acizumab and ehemoradiation in the preoperative or adjuvant treat-merit of patients with stage IL/III rectalcancer显示文摘	Spigel DR Bendell JC McCleod M	2012	Clin Co[orectal Cancer2012，11，：	1
20	A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 ) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy显示文摘	Bodoky G Timcheva C Spigel DR	2012	Invest New Drugs2012，30，3：	1

返回顶部每页显示：

共16页首页上一页第1页下一页末页 /16 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示